Evaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis Bullosa
Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the efficacy and safety of RGN-137 topical gel with
that of placebo gel for treatment of junctional epidermolysis bullosa (JEB) or dystrophic
epidermolysis bullosa (DEB).